Protagonist Therapeutics (PTGX) Earnings Date & Reports

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTGX is expected to report earnings to rise 4,760.00% to $2.43 per share on July 30

Protagonist Therapeutics PTGX Stock Earnings Reports

Q2'26

Est.

$2.43

Q1'26

Beat

by $0.54

Q4'25

Missed

by $0.35

Q3'25

Beat

by $0.01

Q2'25

Beat

by $0.03

The last earnings report on May 05 showed earnings per share of 5 cents, beating the estimate of -49 cents. With 875.27K shares outstanding, the current market capitalization sits at 6.81B.

View a ticker or compare two or three

Compare

PTGX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PTGX